SLE patients with albumin/creatinine levels > 2.5 mg/mmol showed higher percentages of CD19+PLT+, CD4+PLT+, and CD8+PLT+ than those with normal levels (≤2.5 mg/mmol) (Figure 5(d)). The gene discussed is CD8A; the disease is systemic lupus erythematosus.